Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-mark

Moleculin Biotech updates MIRACLE trial for AML and prices a $9.3M offering at $0.75, driving MBRX s

HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or

Prior venetoclax failure - a setting in which published salvage remission rates are approximately 13

Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's r

Access the segment here HOUSTON, July 06, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq

Moleculin Biotech Inc. (NASDAQ:MBRX) stock is trading lower on Tuesday after the company shared prel

Both Annamycin dose arms outperformed control on the primary endpoint of complete remission (CR): 43

Surveyed oncologists reported high likelihood to prescribe (6 of 7), citing deep remissions, transpl

- Access the segment here HOUSTON, June 04, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasd

Independent Cleveland Clinic Cardiac Review Supports Potential Best-in-Class Safety Profile as MIRAC

HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or t

Early blinded results show 40% composite complete remission rate across difficult-to-treat AML patie

Moleculin Biotech Inc. (NASDAQ:MBRX) said it remains on track to unblind the first set of data from

Preliminary blinded CR rate for the first 45 subjects in the trial approximates 30% and represents ~

Pooled analysis of 90 subjects across 5 trials shows stable mean ejection fraction and no clinically

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings

Stocks That Hit 52-Week Lows On Monday